06 Jan 2022  |  Global

Global Diabetes Devices and Services Growth Opportunities

Growth Strategies in an Increasingly Competitive and Digitalized Environment

Infographics

×

The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are def...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices and diagnostic industry. The innovations span the breadth of market segments in the MedTech space such as hematology and immunoassay analyzers, point of care testing solutions for critical care patients, f...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent advances in microbiome technologies, COVID-19 management, cancer treatment, diabetes care, and non-invasive diagnostics. The TOE also provides a list of key industry influencers driving these innovations. The Life Science, Healt...

07 Feb 2020  |  Asia Pacific

Thai Diabetes Devices Market, Forecast to 2023

The Professional Testing Segment will See a High Growth Rate of 10% in this High-cost Device Market

Infographics

×

Diabetes is a growing global concern, with more than 425 million people suffering the world over. Thailand is no exception. It has a high prevalence of about 8%; there were an estimated 4.25 million diabetics in the country in 2018. Unfortunately, only about 56% of this population is actually diagnosed, meaning almost half of those diabetics are di...

07 Feb 2020  |  Asia Pacific

Malaysian Diabetes Devices Market, Forecast to 2023

Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

Infographics

×

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...

06 Feb 2020  |  Asia Pacific

Indonesian Diabetes Devices Market, Forecast to 2023

Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market

Infographics

×

Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...

06 Feb 2020  |  Asia Pacific

Philippine Diabetes Devices Market, Forecast to 2023

Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

Infographics

×

Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...

This edition of the Inside R&D Technology Opportunity Engine (TOE) features trends and innovations in diabetes management, renewable energy, and machine learning. It also provides intelligence on hydrogen fuel generation, all-in-one blood test, and increasing stem cell production. The TOE also features technologies for generating low-cost solar en...

The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across various innovations. The TOE describes disruptive technological developments across stem cell platforms, personalized medicine, use of artificial intelligence for Alzheimer’s disease, gene therapies, melanoma management, biomarkers, vaccin...